European regulator proposes sharp limits on CFDs
The European Securities and Markets Authority is considering a major market intervention into the rules covering contracts for difference and other binary options
Charles Stanley makes first awards under new pay deal
Charles Stanley has signed off the first set of share rewards agreed under the terms of its revised remuneration contrac
Consolidator's assets near double on hectic year of buyouts
Assets under influence at wealth consolidator Harwood near doubled over the year to the end of April
Support for tax and spend rises to 13 year high
Public support for higher levels of public spending – and the taxation to fund it – is at its highest in Britain for a decade
Profile: Brewin's Glasgow boss on rebuilding in Scotland's second city
Brewin's Glasgow office was approaching a staff turnover of 100% in 2015. So how is it now winning awards?
Nine things investors should do to weather the next five years
Pictet's head strategist offers his roadmap for survival between now and 2022
The Expert View: ABF, Dixons Carphone and Boohoo
Our daily roundup of analyst commentary on shares, also including Kier and Stagecoach.
Overnight Markets: Wall Street rallies led by banks, tech stocks
Banking was the best performing S&P sector, with JP Morgan Chase and Bank of America both rising more than 2%.
Thursday Papers: Bondholders take 55% cut in Co-op deal
And global boom would make interest rate rise 'necessary', says Mark Carney.
Damp squib or frontal attack? 15 voices on the FCA funds study
We highlight 15 top views on the Financial Conduct Authority's eagerly awaited final report into the asset management industry.
IBT's Craig on the Trump impact for biotech
Ailsa Craig of the International Biotechnology trust highlights the M&A activity seen in the biotechnology sector this year.
Why this ex-UBS private banker blew the whistle
Bradley Birkenfeld discusses the importance of whistle blowers to society and shares his past experiences with UBS.
The time has come for innovative fund fees
With the FCA study around the corner, Orbis director Dan Brocklebank takes a look at how firms could alter their fee structures to improve the industry's reputation.
How should research be priced in a post-Mifid II world?
Being Mifid II-ready has become a competitive advantage which will set firms apart, according to Brij Malkan from BCA research.